Diagnostic approaches to acute promyelocytic leukaemia

Leukemia and Lymphoma

Volumn 33, Issue 1-2, 1999, Pages 53-63

  O'Connor, Sheila J M ^a   Evans, Paul As ^a   Morgan, Gareth J ^a  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

Acute promyelocytic leukaemia; PML protein; t(15; 17)

Indexed keywords

MONOCLONAL ANTIBODY;

ACUTE MYELOBLASTIC LEUKEMIA; CHROMOSOME TRANSLOCATION; CHROMOSOME TRANSLOCATION 15; CHROMOSOME TRANSLOCATION 17; CYTOGENETICS; DIAGNOSTIC APPROACH ROUTE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; IMMUNOFLUORESCENCE TEST; KARYOTYPING; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW;

EID: 0033044618     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199909093725     Document Type: Review

References (57)

1. Hillestad, L. K. (1957). Acute Promyelocytic Leukaemia. Acta Medica Scandinavica. CLIX, 189-194.
2. Larson, R. A., Kondo, K., Vardiman, J. W., Butler, A. E., Golomb, H. M., & Rowley, J. D. (1984). Evidence for a 15:17 translocation in every patient with acute promyelocytic leukaemia. The American Journal of Medicine, 76, 827-841.
3. Stone, R. M., & Mayor, R. J. (1990). The unique aspects of of acute promyelocytic leukaemia. Journal of Clinical Oncology, 8, 1913-1921.
4. Engel, E., McKee, L. C., & Bunting, K. W. (1967). Chromosomes 17-18 in leukaemias. The Lancet (July 1), 42-43.
5. Golomb, H. M., Rowley, J., Vardiman, J., Baron, J., Locker, G., & Krasnow, S. (1976). Partial deletion of the long arm of chromosome 17. A specific abnormality in acute promyelocytic leukaemia ? Arch Intern Med, 136 (July), 825-828.
6. Rowley, J. D., Golomb, H. M., & Dougherty, C. (1977). 15/17 translocation, a consistent chromosomal change in acute promyelocytic leukaemia. The Lancet(March 5), 549-550
7. Bennet, J. M., Catovsky, D., Daniel, M., Flandrin, G., Galton, D. A. G., Gralnick, H., & Sultan, G. (1985). Proposed revised criteria for the classification of acute myeloid leukaemia. Annals of Internal Medicine. 103, 620-625.
8. Castoldi, G. L., Liso, V., Specchia, G., & Tomasi, P. (1994). Acute Promyelocytic Leukaemia Leukaemia: Morphological Aspects. Leukaemia, 8, 1441-1446.
9. Erber, W. N., Asbahr, H., Rule, S. A., & Scott, C. S. (1994). Unique immunophenotype of acute promyelocytic leukaemia as defined by CD9 and CD68 antibodies. British Journal of Haematology, 88, 101-104.
10. Mancini, M., Nanni, M., Cedrone, M., Diverio, D., Avvisati, G., Riccioni, R., De Cuia, M. R., Fenu, S., & Alimena, G. (1995). Combined cytogenetic. FISH and molecular analysis in acute promyelocytic leukaemia at diagnosis and in complete remission. British Journal of Haematology, 91, 878-884.
11. Grimwade, D., Howe, K., Lanabeer, S., Davies, L., Oliver, F., Walker, H., Swirsky, D., Wheatley, K., Goldstone, A., Burnett, A., & Soloman, E. (1996a). Establishing the pressence of the 1(15:17) in suspected acute promyelocytic leukaemia: cytogenetic, molecular and PML immunofluorescence assessement of patients entered in the MRC ATRA trial. British Journal of Haematology, 94, 557-573.
12. Lemons, R. S., Eilender, D., Waldmann, R. A. Rebentisch, M., Frej, A.-K., Ledbetter, D. H., Willman, C., McConnell, T., & O'Connell, P. (1990). Cloning and characterization of the t(15:17) translocation breakpoint region in acute promyelocytic leukaemia. Genes, Chromosomes & Cancer, 2, 79-87.
13. Burrow, J., Goddard, A. D., Gibbons, B., Katz, F., Swirsky, D., Fioretos, T., Dube, I., Winfield, D. A., Kingston, J., Hageemeijer, A., Rees, J. K., Lister, T. A., & Solomon, E. (1992). Diagnosis of acute promyelocytic leukaemia by RT-PCR: detection of PML-RARα and RARα-PML fusion transcripts. British Journal of Haematology, 82, 529-540.
14. de The, H., Chomienne, C., Lanotte, M., Degos. L., & Dejean, A. (1990). The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor alpha gene to a novel transcriped locus. Nature, 347, 558-561.
15. Kakizuka, A., Miller, W., Umesono, K., Warrell, R., Frankel, S., Murty, V., Dmitrovsky, E., & Evans, R. (1991). Chromosomal translocation t(15:17) in human acute promyelocytic leukaemia fuses RARa with a novel putative transcription factor. PML. Cell, 66(August 23), 663-674.
16. Pandolfi, P., Alcalay, M., Fagioli, M., Zangrilli, D., Mencarelli, A., Diverio, D., Biondi, A., Coco, F. L., Rambaldi, A., Grignani, F., Rochette-Egly, C., Chambon, M.-P., & Pelicci, P.G. (1992). Genomic variability and alternative splicing generate multiple PML/RARalpha transcripts that encode aberrant PML proteins and PML/RARalpha isoforms in acute promyelocytic leukaemia. The EMBO Journal, 11(4), 1397-1407.
17. Flenghi, L., Fagioli, M., Tomassoni, L., Pileri, S., Gambacorta, M., Pacini, R., Grignani, F., Casini, T., Ferrucci, P. F., Martinelli, M. F., Pelicci, P-G., & Falini, B. (1995). Characterization of a new monoclonal antibody (PG-M3) directed against the aminoterminal portion of the PML gene product: immunocytochemical evidence for high expression of PML proteins on activated macrophages, endothelial cells, and epithelia. Blood, 85, 1871-1880.
18. Stuurman, N., deGraaf, A., Floore, A., Josso, A., Humbel, B., deJong, L., & vanDriel, R. (1992). A monoclonal antibody recognising nuclear matrix associated nuclear. Journal of Cell Science, 101, 773-778.
19. Huang, M. E., Ye. Y. C., Chen, S. R., Chai, R., Zhoa, L., Gu, L. J., & Wang, Z. Y. (1988). Use of all trans retinoic acid in the treatment of acute promyelocytic leukaemia. Blood, 72, 567-572.
20. Di Bona, E., Montaldi, A., Guercini, N., Rossi, V., Luciano, A., Bondi, A., & Rodeghiero, F. (1996). A (15:17) translocation not associated with acute promyelocytic leukaenia. British Journal of Haematology, 95, 706-709.
21. Miller, W. H., Kakizuka, A., Frankel, S. R., Warrell, R. P., De Blasio. A., Levine, K., Evans, R. M., & Dmitrovsky, E. (1992). Reverse transcription polymerase chain reaction for the rearranged retinoic acid receptor alpha clarifies diagnosis and detects minimal residual disease in acute promyelocytic leukaemia. Proceedings of the National Academy of Sciences of the United States of America, 89, 2694-2698.
22. Licht, J. D., Chomienne, C., Goy, A., Chen, A., Scott, A. A., Head, D. R., Michaux, J. L., Wu, Y., DeBlasio, A., Miller, W. H., & et al (1995). Clinical and molecular charecterization of a rare syndrome of acute promyelocytic leukaemia associated with translocation (11;17). Blood, 85, 1083-1094.
23. Evans, P., Jack, A., Short, M., Haynes, A., Shiach, C., Owen, R., Johnson, R., & Morgan, G. (1995). A single tube nested RT-PCR for detecting the common myeloid specific chromosomal translocations. Leukaemia, 9, 1285-1290.
24. Martinelli, G., Remiddi, C., Visani, G., PFarabegoli, Testoni, N., Zaccaria, A., Manfroi, S., Cenacchi, A., Russo, D., Bandini, G., Amabile, M., De Vivo, A., & Tura, S. (1995). Molecular analysis of PML-RARα fusion mRNA detected by reverse transcription polymerase chain reaction assay in long term disease free acute promyelocytic leukaemia patients. British Journal of Haematology, 90, 966-968.
25. Biondi, A., Rambaldi, A., Pandolfi, P., Rossi, V., Giudici, G., Alcalay, M., Lo Coco, F., Diverio, D., Pogliani, E. M., Lanzi, E. M., & et al (1992). Molecular monitoring of the myl/retinoic acid receptor-alpha fusion gene in acute promyelocylic leukaemia by polymerase chain reaction. Blood, 80, 492-497.
26. Gallagher, R. E., Li, Y. P., Rao, S., Paietta, E., Andersen, J., Etkind, P., Bennett, J. M., Tallman, M. S., & Wieraik, P. H. (1995). Characterization of acute promyelocytic leukaemia cases with PML-RAR alpha break/fusion sites in PML exon 6: identification of a subgroup with decreased in vitro responsiveness to all-trans retinoic acid. Blood, 86, 1540-1547.
27. Chang, E., Levine, A. M., Slovak, M., Forman, S., & Douer. D. (1996). Acute promyelocytic leukaemia in Latino patients is associated with a high frequency of the bcr 1 breakpoint site in the rearranged PML gene. Blood, 88(Suppl 1, absr 2647), 665a.,
28. Huang, W., Sun, G. L., Li, X. S., Cao, Q., Lu, Y., Jang, G. S., Zhang, F. Q., Chai, R. J., Wang, Z. Y., Waxman, S., & et al (1993). Acute promyelocytic leukaemia: clinical relevance of two major PML-RAR alpha isoforms and detection of minimal residual disease by retrotranscriptase/polymerase chain reaction to predict relapse. Blood, 82, 1264-1269.
29. Fukutani, H., Naoe, T., Ohno, R., Yoshida, H., Miyawaki, S., Shimazaki, C., Miyake, T., Nakayama, Y., Kobayashi, H., Goto, S., & et al (1995b). Isoforms of PML-retinoic acid receptor alpha fused transcripts affect neither clinical features of acute promyelocytic leukaemia nor prognosis after treatment with all-trans retinoic acid. The Leukaemia Study Group of the Ministry of Health and Welfare (Kohseisho). Leukaemia, 9, 1478-1482.
30. Alcalay, M., Zangrilli, D., Pandolfi, P. P., Mencarelli, A., LoCoco, F., Biondi, A., Grignani, F., & Pelicci, P. G. (1992). Expression pattern of the RARα/PML fusion gene in acute promyelocytic leukaemia. Proceedings of the National Academy of Sciences of the United States of America, 89, 4840-4844.
31. Tobal, K., Saunders, M. J., Grey, M. R., & Yin, J. A. (1995). Persistence of RAR alpha/PML fusion mRNA detected by reverse transcriptase polymerase chain reaction in patients with long term remission of acute promyelocytic leukaemia. British Journal of Haematology, 90, 615-618.
32. Grimwade, D., Howe, K., Langabeer, S., Burnett, A., Goldstone, A., & Solomon, E. (1996b). Minimal residual disease detection in acute promyelocytic leukaemia by reverse transcriptase PCR: evaluation of PML-RARα and RARα-PML assessment in patients who ultimately relapse. Leukemia, 10. 61-66.
33. Scale, J. R., Varma, S., Swirsky, D. M., Pandolfi, P. P., Goldman, J. M., & Cross, N. C. (1996). Quantification of PML-RAR alpha transcripts in acute promyelocytic leukaemia: explanation for the lack of sensitivity of RT-PCR for the detection of minimal residual disease and induction of the leukaemia specific mRNA by alpha Interferon [see comments]. British Journal of Haematology, 95, 95-101.
34. Zhao, L., Chang, K. S., Estey, E. H., Hayes, K., Deisseroth, A. B., & Liang, J. C. (1995). Detection of residual leukaemic cells in patients with acute promyelocytic leukaemia by the fluorescence in situ hybridisation method: potential for predicting relapse. Blood, 85, 495-199.
35. Dyck, A. J., Warrell, R. P., Evans, R. M., & Miller, W. H. (1995). Rapid Diagnosis of acute promyelocytic leukaemia by immunohistochemical localisation of PML/RARalpha protein. Blood, 86, 862-867.
36. Miller, W. H., Levine, K., De Blasio, A., Frankel, S. R., Dmitrovsky, E., & Warrell, R. P. (1993). Detection of minimal residual disease in acute promyelocytic leukaemia by a reverse transcription polymerase chain reaction assay for the PML-RAR alpha fusion mRNA. Blood, 82, 1689-1694.
37. Chen, S. J., Chen, Z., Chen, A., Tong, J. H., Dong, S., Wang, Z. Y., Waxman, S., & Zelent, A. (1992). Occurrence of distinct PML-RAR-alpha fusion gene isoforms in patients with acute promyelocytic leukaemia detected by reverse transcription polymcrase chain reaction. Oncogene, 7, 1223-1232.
38. Lo Coco, F. Diverio, D., Pandoldi, P. P., Biondi, A., Rossi, V., Avvisati, G., Rambaldi, A., Arcese, W., Petti, M. C. & Meloni, G. (1992). Molecular evaluation of residual disease as a predictor of relapse in acute promyelocytic leukaemia. Lancet, 340, 1437-1438.
39. Takatsuki, H., Umenura, T., Sadamura, S., Yamashita, S., Goto, T., Abe, Y., Yufu, Y., Inaba, S., Nishimura, J., & Nawata, H. (1995). Detection of minimal residual disease by reverse transcriptase polymerase chain reaction for the PML/RAR alpha fusion mRNA: a study in patients with acute promyelocytic leukaemia following peripheral stem cell transplantation. Leukemia, 9, 889-892.
40. Fukutani, H., Naoe, T., Ohno, R., Yoshida, H., Kiyoi, H., Miyawaki, S., Morishita, H., Sano, F., Kamibayashi, H., Matsue, K. & et al (1995a). Prognostic significance of the RT-PCR assay of PML-RARα transcripts in acute promyelocytic leukaemia. The Leukaemia Study Group of the Ministry of Health and Welfare (Kohseisho). Leukaemia, 9, 588-593.
41. Diverio, D., Pandolfi, P. P., Rossi, V., Biondi, A., Pelicci, G., & LoCoco, F. (1994). Monitoring of treatment outcome in acute promyelocytic leukaemia by RT-PCR. [Review]. Leukaemia, 8, 1105-1107.
42. Fenaux, P., LeDely, M. C., Castaigne, S., Archimbaud, E., Chomienne, C., Link, H., Guerei, A., Duarte, M., Daniel, M. T., Bowden, D., Huebner, G., Bauters, F., Fegueux, N., Fey, M., Sunz, M., Lowwnbery, B., Maloisel, F., Auzanneau, G., Sadoun, A., Gaedin, C., Bastion, Y., Ganser, A., Jacky, E., Dombert, H., Castang, C., Dogos, L., & The European APL91 Group (1993). Effect of all trans retinoic acid in newly diagnosed acute promyelocytic leukaemia. Results of a multicentre randomised trial. Blood, 82, 3241-3249.
43. Cross, N. C., Feng, L., Bungey, J., & Goldman, J. M. (1993). Minimal residual disease after bone marrow transplant for chronic myeloid leukaemia detected by the polymerase chain reaction. Leukaemia & Lymphoma, 11 (Suppl), 39-43.
44. Tobal, K., & Yin, J. A. (1996). Monitoring of minimal residual disease by quantitative reverse transcriptase polymerase chain reaction for AMLI-MTG8 transcripts in AML-M2 with t(8:21). Blood, 88, 3704-3709.
45. Hebert, J., Cayuela, J. M., Daniel, M. T., Berger, R., & Sigaux, F (1994). Detection of minimal residual disease in acute myelomonocytic leukaemia with abnormal marrow cosinophils by nested polymerase chain reaction with allele specific amplification. Blood, 84, 2291-2296.
46. Nucifora, G., Larson, R. A., & Rowley, J. D. (1993). Persistance of the 8:21 translocation in patients with acute myeloid leukaemia type M2 in long term remission. Blood, 82, 712.
47. Evans, P. A., Short, M. A., Jack, A. S., Norfolk, D. R., Child, J. A., Shiach, C. R., Davies, F. E., Tobal, K., Yin, J. A., & Morgan, G. J. (1997). Detection and quantitation of the CBF-beta/MYH11 transcripts associated with the inv (16) in presentation and follow-up samples from patients with AML. Leukemia, 11, 364-369.
48. Marcucci, G. (1997). ASH abstract 1735. Blood.
49. Shad, C. R., Hanson, C. A., Paietta, E., Casper, J., Jalal, S. M., & Dewald, G. W. (1994). Efficacy of fluorescence in situ hybridisation for detecting PML/RARα gene fusion in treated and untreated acute promyelocytic leukaemia. Mayo Clinic Proceeding, 69, 1 1047-1053
50. Tanaka, K., Arif, M., & et al (1997). Application of fluorescence in situ hybridisation to detect residual leukaemic cells with9:22 and 15:17 translocation. Leukemia, 11, 436-440.
51. Daniel, M. T., Koken, M., Romagne, O., Barbey, S., Bazarbachi, A., Stadler, M., Guillemin, M. C., Degos, L., Chomienne, C., & deThe, H. (1993). PML protein expression in haematopoietic and acute promyelocytic leukaemia cells. Blood, 82, 1858-1867.
52. Koken, M. H. M., Puvion-Dutilleul, F., Guillemin, M. C., Viron, A., Linares-Crux, G., Stuurman, N., deJong, L., Szostecki, C., Calvo, F., Chomienne, C., Dogos, L., Puvion, E., & deThe, H. (1994). The t(15;17) translocation alters a nuclear body in a retinoic acid reversible fashion. EBMO Journal, 13, 1073-1083.
53. Falini, B., Flenghi, L., Fagioli, M., Coco, F. L., Cardone, I., Diverio, D., Pasquelucci, L., Biondi, A., Riganelli, D., Orleth, A., Liso, A., Martelli, M. F., Pelicci, P.-G., & Pileri, S. (1997). Immunocytochemical diagnosis of acute promyelocytic leukaemia (M3) with the monoclonal antibody PG-M3. Blood, 90(10), 4046-4053.
54. O'Connor, S. J., Forsyth, P. D., Dalal, S., Evans, P. A., Short, M. A., Shiach, C., Jack, A. S., & Morgan, G. J. (1997). The rapid diagnosis of acute promyelocytic leukaemia using PML (5E10) monoclonal antibody. British Journal of Haematology, 99, 597-604.
55. Diverio, D., Pandolfi, P.P., Biondi, A., Avvisati, G., Petti, M.C., Mandelli, F., Pelicci, G., Lo Coco, F. (1993). Absence of reverse transcription-polymerase chain reaction detectable residual disease in patients with acute promyelocytic leukaemia in long term remission. Blood 82, 3556-3559.
56. Anon, (1996). RT-PCR in acute promyelocytic leukaemia: second workshop of the European Retinoic Group. Paris, France, 17-18 December 1994. Leukemia 10, 368
57. Grimwade, D., Langabeer, S., Howe, K., Walker, H., Wheatley, K., Harrison, G., Goldstone, A. (1998). The role of molecular diagnosis & residual disease monitoring in APL: Results of the MRC ATRA trial. British Journal of Haematology, 101(Suppl 1)., Abstract 322